NCT00897663 - Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Brain and Central Nervous System Tumors

Interventions

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

protein expression analysis

OTHER

diagnostic laboratory biomarker analysis

OTHER

immunohistochemistry staining method

Trial Locations (10)

32224

Mayo Clinic - Jacksonville, Jacksonville

51101

Siouxland Hematology-Oncology Associates, LLP, Sioux City

51102

Mercy Medical Center - Sioux City, Sioux City

51104

St. Luke's Regional Medical Center, Sioux City

55905

Mayo Clinic Cancer Center, Rochester

57701

Rapid City Regional Hospital, Rapid City

58501

Medcenter One Hospital Cancer Care Center, Bismarck

Mid Dakota Clinic, PC, Bismarck

58502

St. Alexius Medical Center Cancer Center, Bismarck

85259-5499

Mayo Clinic Scottsdale, Scottsdale

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER